A Prospective, Phase I/II Study of Everolimus and Temozolomide in Patients with Advanced Pancreatic Neuroendocrine Tumor

BACKGROUND: Both everolimus and temozolomide are associated with single-agent activity in patients with pancreatic neuroendocrine tumor (NET). We performed a phase I/II study to evaluate the safety and efficacy of temozolomide in combination with everolimus in patients with advanced pancreatic NET....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Chan, Jennifer A., Blaszkowsky, Lawrence, Stuart, Keith, Zhu, Andrew X., Allen, Jill, Wadlow, Raymond, Ryan, David P., Meyerhardt, Jeffrey, Gonzalez, Marielle, Regan, Eileen, Zheng, Hui, Kulke, Matthew H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308727/
https://ncbi.nlm.nih.gov/pubmed/23733618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados